Literature DB >> 11315976

Anterior ischemic optic neuropathy associated with viagra.

A V Cunningham1, K H Smith.   

Abstract

A 42-year-old male presented with acute onset of an inferior visual field defect OD after sildenafil citrate use. Examination revealed a right relative afferent pupillary defect and a swollen disc with a 0.1 cup-to-disc ratio and a prominent disc hemorrhage. Anterior ischemic optic neuropathy (AION) is associated with acute episodes of hypotension in patients with structurally crowded discs. Sildenafil citrate may cause episodes of hypotension and was temporally related to the onset of symptoms in this patient. Because patients are often reluctant to volunteer their history of sildenafil citrate use, the physician may need to ask specifically about use of this medication. Physicians should counsel patients with crowded optic discs and a history of nonarteritic anterior ischemic optic neuropathy in one eye that use of sildenafil citrate might increase their risk of ischemic optic neuropathy in the fellow eye.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11315976     DOI: 10.1097/00041327-200103000-00006

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  23 in total

1.  Can erectile dysfunction drug use lead to ischaemic optic neuropathy?

Authors:  H D Pomeranz
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

2.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

Review 3.  Drug treatment of pulmonary hypertension in children.

Authors:  Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

4.  Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction.

Authors:  G McGwin; M S Vaphiades; T A Hall; C Owsley
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 5.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Pulmonary embolism after tadalafil ingestion.

Authors:  Huang-Chi Chen; Chuan-Sheng Wang; Shu-Hui Chuang; Cheng-Yuan Wang
Journal:  Pharm World Sci       Date:  2008-06-13

Review 7.  Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

8.  Udenafil: efficacy and tolerability in the management of erectile dysfunction.

Authors:  Sung Gu Kang; Je Jong Kim
Journal:  Ther Adv Urol       Date:  2013-04

Review 9.  Drug Treatment of Pulmonary Hypertension in Children.

Authors:  Catherine M Avitabile; Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

10.  Effect of DA-8159, a selective phosphodiesterase type 5 inhibitor, on electroretinogram and retinal histology in rabbits.

Authors:  Ho Kyun Cho; Kyung Koo Kang; Gook Jun Ahn; Hyun Joo Shim; Won Bae Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.